近年来,国内外对原发性肝癌(简称肝癌)的研究普遍加强,肝癌患者的生存期虽有延长,但仍不显著。本组224例的病后和治后一年生存率分别为30.4%和24.6%,已死亡的198例病后和治后平均生存期为7.9月和5.5月,比近十年国内外大多数报道略有提高。本文试就224例肝癌的临床和病理资料,从肿瘤、机体和治疗等方面探讨影响肝癌预后的有关因素。 In recent years, research on primary liver cancer (abbreviated as liver cancer) has generally been strengthened at home and abroad. Although the survival period of liver cancer patients has been prolonged, it is still not significant. The post-mortem and post-treatment survival rates of the 224 patients in this group were 30.4% and 24.6%, respectively. The post-mortem and post-treatment survival of 198 patients who died were 7.9 months and 5.5 months, which is more than the domestic and international The report slightly improved. In this paper, the clinical and pathological data of 224 cases of hepatocellular carcinoma were explored, and related factors affecting the prognosis of liver cancer were explored from the aspects of tumor, body and treatment.